Need answers or support?  Call 866-228-4673

COMPARTIVE MULTIDIMENSIONAL MOLECULAR ANALYSES OF PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA REVEALS DISTINCT MOELCULAR SUBTYPES

Friday, December 6, 2013

Acta Neuropathologica

December 2013

·         Amanda M. SaratsisMadhuri KambhampatiKendall SnyderSridevi YadavilliJoseph M. Devaney, Brennan HarmonJordan HallEric H. RaabePing AnMelanie Weingart

 Get Access

Abstract

Diffuse intrinsic pontine glioma (DIPG) is a highly morbid form of pediatric brainstem glioma. Here, we present the first comprehensive protein, mRNA, and methylation profiles of fresh-frozen DIPG specimens (n = 14), normal brain tissue (n = 10), and other pediatric brain tumors (n = 17). Protein profiling identified 2,305 unique proteins indicating distinct DIPG protein expression patterns compared to other pediatric brain tumors. Western blot and immunohistochemistry validated upregulation of Clusterin (CLU), Elongation Factor 2 (EF2), and Talin-1 (TLN1) in DIPGs studied. Comparisons to mRNA expression profiles generated from tumor and adjacent normal brain tissue indicated two DIPG subgroups, characterized by upregulation of Myc (N-Myc) or Hedgehog (Hh) signaling. We validated upregulation of PTCH, a membrane receptor in the Hh signaling pathway, in a subgroup of DIPG specimens. DNA methylation analysis indicated global hypomethylation of DIPG compared to adjacent normal tissue specimens, with differential methylation of 24 genes involved in Hh and Myc pathways, correlating with protein and mRNA expression patterns. Sequencing analysis showed c.83A>T mutations in the H3F3A or HIST1H3B gene in 77 % of our DIPG cohort. Supervised analysis revealed a unique methylation pattern in mutated specimens compared to the wild-type DIPG samples. This study presents the first comprehensive multidimensional protein, mRNA, and methylation profiling of pediatric brain tumor specimens, detecting the presence of two subgroups within our DIPG cohort. This multidimensional analysis of DIPG provides increased analytical power to more fully explore molecular signatures of DIPGs, with implications for evaluating potential molecular subtypes and biomarker discovery for assessing response to therapy.

 

Purchase on Springer.com

$39.95 / €34.95 / £29.95*

 

* Final gross prices may vary according to local VAT.

Share/Save

©2009 Children's Brain Tumor Foundation.    1460 Broadway, New York, NY 10036    (866) 228-4673    info@cbtf.org

Privacy Policy   |   Site Map
 

X
Loading